We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| GE Aerospace | NYSE:GE | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -1.70 | -1.03% | 162.79 | 166.2558 | 162.1903 | 163.56 | 2,613,523 | 17:04:54 |
From Apr 2019 to Apr 2024
By Nathan Allen
Swiss pharmaceutical company Lonza Group AG (LONN.EB) said Monday that it has signed an agreement to set up a manufacturing plant for biological products in China's Guangzhou province using technology provided by GE Healthcare.
The facility will be based on GE Healthcare's off-the-shelf KUBio manufacturing platform and should come online by 2020, Lonza said.
The plant forms part of a larger biomanufacturing initiative between GE Healthcare and Guangzhou Development District, Lonza said.
Write to Nathan Allen at nathan.allen@dowjones.com
(END) Dow Jones Newswires
December 10, 2018 03:44 ET (08:44 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year GE Aerospace Chart |
1 Month GE Aerospace Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
